Detalles de la búsqueda
1.
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.
Proc Natl Acad Sci U S A;
119(15): e2109617119, 2022 04 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353605
2.
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Brain;
146(6): 2570-2583, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36975162
3.
Cross-sectional proteomic expression in Parkinson's disease-related proteins in drug-naïve patients vs healthy controls with longitudinal clinical follow-up.
Neurobiol Dis;
177: 105997, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634823
4.
Uncovering a neurological protein signature for severe COVID-19.
Neurobiol Dis;
182: 106147, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37178811
5.
Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.
Int J Mol Sci;
23(23)2022 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36498957
6.
Cerebrospinal α-Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort.
Mov Disord;
36(9): 2048-2056, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33978256
7.
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.
Mov Disord;
35(2): 288-295, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31737952
8.
Retraction Notice to: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.
Mol Ther;
32(6): 2034, 2024 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608700
9.
Retraction Notice to: Corrigendum to "Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders".
Mol Ther;
32(6): 2035, 2024 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38608701
10.
CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson's Disease.
Int J Mol Sci;
21(22)2020 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198266
11.
Parkinson's disease biomarkers based on α-synuclein.
J Neurochem;
150(5): 626-636, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31265130
12.
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
J Neuroinflammation;
15(1): 129, 2018 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29716614
13.
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration.
J Neuroinflammation;
15(1): 169, 2018 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29843738
14.
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
Mov Disord;
33(11): 1724-1733, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30440090
15.
Differential effects of immunotherapy with antibodies targeting α-synuclein oligomers and fibrils in a transgenic model of synucleinopathy.
Neurobiol Dis;
104: 85-96, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28476636
16.
Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects.
J Neural Transm (Vienna);
124(6): 721-738, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28477284
17.
Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice.
Brain;
139(Pt 3): 856-70, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26719384
18.
Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.
Mol Ther;
24(4): 746-58, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26700614
19.
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.
Mov Disord;
31(10): 1535-1542, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27548849
20.
Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
Neurobiol Dis;
78: 100-14, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25818009